MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic nervous system"

  • 2017 International Congress

    Normal “heart” in Parkinson’s disease: Is this a distinct clinical phenotype?

    J.E. Lee, J.-S. Kim, Y.-S. Oh, D.-W. Ryu, I.-U. Song, K.-S. Lee (Seoul, Republic of Korea)

    Objective: The aim of this study was to investigate whether non-motor manifestations of Parkinson’s disease (PD) differ between patients with normal and abnormal myocardial metaiodobenzylguanidine (MIBG)…
  • 2017 International Congress

    Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease

    M. Bhargava, S. Bhargava, V. Bhargava (Kanpur, India)

    Objective: Objective of this study is to develop delivery-system to overcome BBB by employing novel, non-invasive approach via nasal route. The olfactory neural pathway provides…
  • 2017 International Congress

    The autonomic nervous system in Friedreich´s Ataxia: preliminary findings

    E. Indelicato, A. Fanciulli, J. Wanschitz, W. Nachbauer, W. Poewe, G. Wenning, S. Boesch (Innsbruck, Austria)

    Objective: To investigate the autonomic function in Friedreich´s ataxia (FRDA)   Background: FRDA is a hereditary neurodegenerative disorder characterized by progressive gait ataxia, limb dysmetria, dysarthria…
  • 2017 International Congress

    Two-year prospective study reveals that gut dysbiosis predicts progression of Parkinson’s disease

    M. Hirayama, T. Minato, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, T. Maeda, K. Ohno (Nagoya, Japan)

    Objective:  This study is to examine whether intestinal microbiota correlate with pathology progress of PD severity and change of gut microbiota for 2 years. Background:…
  • 2017 International Congress

    Nonmotor disorders in Parkinsonism: Experience in Kyrgyz Republic

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: Investigate existence and evidence of the nonmotor disorders, particularly neuropsychological disorders and autonomic dysfunctions in PD and vascular Parkinsonism patients. Background: Nonmotor disorders accompany…
  • 2016 International Congress

    Can deep brain stimulation implantation cause multiple system atrophy? A retrospective review of MSA patients

    E.A. Coon, B.T. Klassen, J.E. Ahlskog, P.A. Low, W. Singer (Rochester, MN, USA)

    Objective: To evaluate whether implantation of deep brain stimulation (DBS) could lead to multiple system atrophy (MSA). Background: Recent studies regarding the transmissibility of alpha-synuclein…
  • 2016 International Congress

    Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism

    S. Tashiro, K. Dashtipour, J.J. Chen, K. Frei, E. Rashidian (Loma Linda, CA, USA)

    Objective: The aim of this study was to review the published evidence for the efficacy, safety, and dosing practices of droxidopa treatment for symptomatic neurogenic…
  • 2016 International Congress

    The influences of STN-DBS and levodopa on cardiovascular autonomic function in patients with Parkinson’s disease: Evaluated by trigonometric regressive spectral analysis

    K. Li, M. Wolz, R. Haase, H. Reichmann, T. Ziemssen (Dresden, Germany)

    Objective: To explore the effects of STN-DBS and levodopa on cardiovascular autonomic function in PD. Background: Cardiovascular autonomic dysfunction has been shown in patients with…
  • 2016 International Congress

    Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation

    M. Carmona-Abellán, I. Marcilla, I. Martínez-Valbuena, T. Tuñón, R. Luquin-Piudo (Pamplona, Spain)

    Objective: To study the cardiac sympathetic innervation and its relationship with the incidence of alpha-synuclein deposits in heart tissue of synucleinopathies and asymptomatic control patients.…
  • 2016 International Congress

    Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

    F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)

    Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley